loader2
Partner With Us NRI

Company details

2,078.45
2,185.00
1,963.90
2,851.75
6M Return -16.32%
1Y Return -18.29%
Mkt Cap.(Cr) 1,804.33
Volume 329
Div Yield 0.46%
OI
-
OI Chg %
-
Volume 329

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Our Research View

Trading recommendation

Data not found

Investment recommendation

Call Date

24 May 2022

Entry Price

2,277.00

Target Price

2,445.00

Duration

12-18 Month

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 228.31 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 20,245.34 -48,746.54
LAST 3M 72,514.10 -88,466.89
LAST 6M 139,386.11 -218,253.53
LAST 12M 231,426.55 -250,977.27

Information

  • About Company
  • Company Info
  • Listing Info
46.78
53.73%
305.6201
23.26%
18.11%
Description
  • Incorporated as a private limited company in Apr.`87, Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.`93. HPL markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium. The company`s own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation. During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun. The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry vaccines.

Read More

Registered Address

1st Flr PushpakPachvati Circle, Motilal Hirabhai Road, Ahmedabad, Gujarat, 380006

Tel : 91-079-26445107
Email : mail:hester.in
Website : http://www.hester.in

Registrar

Sharepro Services India Pvt Lt

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524669
NSE Code : HESTERBIO
Book Closure Date (Month) : Aug
BSE Group : A
ISIN : INE782E01017

ICICIdirect Hester Biosciences Ltd FAQ

You can buy Hester Biosciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Hester Biosciences Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jul 01, 2022 04:01 PM the closing price of Hester Biosciences Ltd was ₹ 2,121.00.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jul 01, 2022 04:01 PM, the market cap of Hester Biosciences Ltd stood at ₹ 1,804.33.
The latest PE ratio of Hester Biosciences Ltd as of Jul 01, 2022 04:01 PM is 46.78
The latest PB ratio of Hester Biosciences Ltd as of Jul 01, 2022 04:01 PM is 0.14
The 52-week high of Hester Biosciences Ltd is ₹ 2,851.75 while the 52-week low is ₹ 1,963.90 .
According to analyst recommendations, Hester Biosciences Ltd has a “Buy” rating for the long term.

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE